Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 10/20 | 0.45 |
| ▸ | CTSD | P07339 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LAP3 | P28838 | 3/20 | 0.41 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29349740 | 1.00 | SLC7A5 (0.47) | SLC7A5BACE1CTSDALDH1A1MAPT | |
| SCHEMBL3066882 | 1.00 | SLC7A5 (0.47) | SLC7A5BACE1CTSDALDH1A1MAPT | |
| SCHEMBL30288012 | 0.97 | BACE1 (0.48) | SLC7A5BACE1CTSDBACE2 | |
| SCHEMBL30011009 | 0.97 | BACE1 (0.48) | SLC7A5BACE1CTSDBACE2 | |
| SCHEMBL31307239 | 0.93 | BACE1 (0.45) | BACE1CTSDBACE2 | |
| SCHEMBL8651654 | 0.92 | SLC7A5 (0.55) | SLC7A5BACE1CTSDALDH1A1MAPT | |
| SCHEMBL31345674 | 0.92 | SLC7A5 (0.55) | SLC7A5BACE1CTSDALDH1A1MAPT | |
| SCHEMBL3057410 | 0.92 | SLC7A5 (0.55) | SLC7A5BACE1CTSDALDH1A1MAPT | |
| SCHEMBL3057413 | 0.92 | SLC7A5 (0.55) | SLC7A5BACE1CTSDALDH1A1MAPT | |
| SCHEMBL9359613 | 0.92 | SLC7A5 (0.55) | SLC7A5BACE1CTSDALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6126 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062447-A1 | COMPOUNDS | UNIV SOUTHAMPTON (GB) | 2026-03-05 | — | — | US | claimed |
| EP-4577555-A1 | COMPOUNDS | UNIVERSITY OF SOUTHAMPTON (GB) | 2025-07-02 | — | — | EP | claimed |
| CN-113631033-B | Treatment of diseases associated with ENPP1 or ENPP3 deficiency | 依诺兹梅制药公司 | 2024-10-15 | — | — | CN | claimed |
| WO-2024042313-A1 | COMPOUNDS | UNIVERSITY OF SOUTHAMPTON (GB) | 2024-02-29 | — | — | WO | claimed |
| WO-2022148418-A1 | PHARMACEUTICAL COMPOSITION CAPABLE OF BEING DELIVERED BY METERED DOSE INHALER | 江苏恒瑞医药股份有限公司 | 2022-07-14 | — | — | WO | claimed |
| CN-116410307-B | Neutralizing antibody for neutralizing SARS-CoV-2 in six strains and its application | TSINGHUA UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| CN-106987570-B | Cas9 nuclease R780A and application thereof | SHANGHAI JIAO TONG UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-116194479-B | Anti-TAU antibodies | GT创新公司 | 2026-05-22 | — | — | CN | disclosed |
| CN-113583116-B | Antibodies against SARS-CoV-1 or SARS-CoV-2 and uses thereof | 养生堂有限公司 | 2026-05-22 | — | — | CN | disclosed |
| CN-113881680-B | T cell antigen receptor, multimeric complex thereof, and preparation method and application thereof | 华夏英泰（北京）生物技术有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-113853432-B | Novel polypeptides for producing patchoulol and/or drimenol compounds | 弗门尼舍有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20070065371-A2 | Novel Dry Powder Inhalation System For Transpulmonary Administration | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-03-22 | — | — | US | disclosed |
| EP-1402913-B1 | DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION, METHOD OF MANUFACTURING A DRY POWDERED PREPARATION, AND USE OF A FREEZE DRIED COMPOSITION | OTSUKA PHARMA CO LTD (JP) | 2006-08-23 | — | — | EP | disclosed |
| EP-1688133-A1 | Freeze-dried composition for transpulmonary administration | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-08-09 | — | — | EP | disclosed |
| EP-1688134-A2 | Dry powder inhaler for transpulmonary administration | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-08-09 | — | — | EP | disclosed |
| US-20060073105-A1 | Novel dry powder inhalation system for transpulmonary administration | YAMASHITA CHIKAMASA | 2006-04-06 | — | — | US | disclosed |
| EP-1579855-A1 | NOVEL DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-09-28 | — | — | EP | disclosed |
| EP-1402913-A1 | DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-20030101995-A1 | Dry powder inhalation system for transpulmonary administration | OTSUKA PHARMACEUTICAL CO., LTD. | 2003-06-05 | — | — | US | disclosed |